Regeneus Ltd (ASX:RGS)

Regeneus Ltd (ASX:RGS)


Share Price
$ 0.11
Change
-0.005 (-4.55 %)
Market Cap
$21.93 m
Proactive Investors - Run By Investors For Investors

Regeneus Ltd

Regeneus Ltd (ASX:RGS) is a clinical-stage regenerative medicine company developing a portfolio of cell therapies with a focus on musculoskeletal disease, oncology and dermatology.

EPIC: RGS
Market: ASX:RGS
52-week High/Low: A$0.27 / A$0.10
Sector: Pharma & Biotech
Market Cap: $21.93 m
Website: www.regeneus.com.au
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Regeneus Ltd


Regeneus Ltd Timeline

Columns Including RGS

VIEW ALL
Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use